The Southern Company publishes First Supplemental Indenture for 2.125% Notes
The company filed a supplement to establish terms for $525 million 2.125% convertible senior notes due 2027.
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
The company filed a supplement to establish terms for $525 million 2.125% convertible senior notes due 2027.
FHLB Pittsburgh issued $535M debt across two bond series, deploying long-term fixed and floating rate funding while avoiding variable-rate call provisions.
Scholar Rock Holding Corp filed a July 7, 2026 Form 8-K to file a prospectus supplement for an offering of up to $200M in common stock, with legal counsel affirming the registratio…
CG Oncology engaged legal counsel for an Offering of Shares pursuant to an Open Market Sale Agreement. As a biopharma developer of drugs for urothelial cancer, successful capital r…
Agenus reported Q2 2026 results and announced an accelerated Phase 3 trial for neoadjuvant colon cancer. The trial is fully funded via a July 2026 private placement and addresses a…
BioVie reported that the Phase 2 SUNRISE-PD trial of bezisterim was successful, showing significant improvements in motor and non-motor symptoms of early Parkinson's disease patien…
Safe Pro secured a $780,000 purchase order from a Department of War prime contractor for its threat detection and Blue UAS technologies, marking its fifth recent U.S. government aw…
Tarsus Pharmaceuticals, Inc. issued a pre-funded warrant to purchase up to a total of shares of common stock with an exercise price of $0.0001. The warrant is part of a series issu…
Lithium Americas entered into a securities purchase agreement for up to $175 million in convertible debentures. The funding strengthens balance sheet ahead of peak construction at …
ERP Operating Limited Partnership priced an offering for $600M of 4.950% notes due 2031 and $400M of 5.450% notes due 2036. The deal is being jointly led by Morgan Stanley, Wells F…
SHF Holdings concluded a temporary period that lowered its Series B Preferred Stock and warrant prices, reestablishing a conversion price of $1.5528. This move follows the conversi…
Twist Bioscience Corporation agreed to issue 3,125,000 shares of common stock, with up to 468,750 additional shares available at the underwriters' option, via an automatic shelf re…
Newell Brands plans to offer $500 million of Notes to redeem $500 million of 2027 Notes. The debt issuance is subject to market conditions and general regulatory approvals for Rule…
Glucotrack issued a senior secured convertible promissory note to an investor. The issuance indicates liquidity activity on the part of the company.
AbbVie priced $12.05 billion in aggregate face value of senior notes across multiple series, arranged by Morgan Stanley & Co. LLC, BofA Securities, Inc., J.P. Morgan Securities LLC…
Vireo Growth Inc., SB Ohio Holdings Inc., Chicago Atlantic Credit Opportunities, LLC, and PharmaceuticalRX, LLC have executed a Securities Purchase Agreement dated July 30, 2026, d…
My Size entered an agreement with Square Gate Capital to sell up to $10M of common stock as a partnership agreement, pending necessary stockholder approval.
Wilco 63 announced the separate trading of its Class A ordinary shares and warrants on the Nasdaq Global Market under the symbols WLCO and WLCOW, commencing August 10, 2026. The ex…
ClearOne Inc. agreed to cancel stock purchase warrants belonging to First Finance Ltd., extinguishing the holder's rights to acquire shares of common stock.
Xenia Hotels & Resorts entered an equity distribution agreement with a syndicate of five banks to sell up to $500 million in shares in a public offering. This sale is anticipated t…